Literature DB >> 21478754

Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography.

Gabrielle Sarlon-Bartoli1, Nicolas Michel, David Taieb, Julien Mancini, Camille Gonthier, François Silhol, Cyril Muller, Jean-Michel Bartoli, Frédéric Sebag, Jean-François Henry, Jean-Claude Deharo, Bernard Vaisse.   

Abstract

OBJECTIVE: To assess the additional value of adrenal venous sampling (AVS) to diagnose primary aldosteronism sub-types in patients who have a unilateral nodule detected by computed tomography (CT scan) and who should undergo an adrenalectomy.
METHODS: A retrospective study to assess consecutive patients with primary aldosteronism undergoing an adrenal CT scan and AVS. Criterion for selective cannulation was an equal or higher cortisol level in the adrenal vein compared to the inferior vena cava. An adrenal-vein aldosterone-to-cortisol ratio of at least two times higher than the other side defined lateralization of aldosterone production.
RESULTS: Sixty-seven patients (mean age 52 years, 39 men) underwent a CT scan and AVS. In nine patients (13%), cannulation of the right adrenal vein led to a technical failure. Both procedures led to diagnosis of 29 patients with adenoma-producing aldosterone (APA; 50%), 23 bilateral adrenal hyperplasias (40%), and six unilateral adrenal hyperplasias (10%). Of the 45 patients with a nodule detected by CT, subsequent AVS showed bilateral secretion in 16 patients (36%). Compared to the strategy of coupling CT scans with AVS to diagnosis APA, a CT scan alone had an accuracy of 72.4% (P < 0.001). Among patients with a macronodule detected by CT, 13 (37%) had bilateral secretion as assessed by AVS. The patients with a macronodule detected by CT alone had the same risk of a discrepancy as those with a small nodule (P = 0.99).
CONCLUSION: AVS is essential to diagnose the unilateral hypersecretion of aldosterone, even in patients in whom a unilateral macronodule is detected by CT, to avoid unnecessary surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478754     DOI: 10.1097/HJH.0b013e32834666af

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Adrenal gland: uncertainty in the selective use of adrenal vein sampling.

Authors:  Klara J Rosenquist; Robert G Dluhy
Journal:  Nat Rev Endocrinol       Date:  2011-06-21       Impact factor: 43.330

2.  Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism.

Authors:  K Kamemura; N Wada; T Ichijo; Y Matsuda; Y Fujii; T Kai; T Fukuoka; R Sakamoto; A Ogo; T Suzuki; H Umakoshi; M Tsuiki; M Naruse
Journal:  J Hum Hypertens       Date:  2016-09-01       Impact factor: 3.012

3.  Is adrenal venous sampling mandatory before surgical decision in case of primary hyperaldosteronism?

Authors:  Augustin Pirvu; Nora Naem; Jean Philippe Baguet; Frédéric Thony; Olivier Chabre; Philippe Chaffanjon
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

4.  A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia.

Authors:  Shao-bo Jiang; Xu-dong Guo; Han-bo Wang; Ruo-zhen Gong; Hui Xiong; Zheng Wang; Hai-yang Zhang; Xun-bo Jin
Journal:  Int Urol Nephrol       Date:  2014-02-02       Impact factor: 2.370

5.  Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis.

Authors:  Yaqiong Zhou; Dan Wang; Licheng Jiang; Fei Ran; Sichao Chen; Peng Zhou; Peijian Wang
Journal:  BMJ Open       Date:  2020-12-31       Impact factor: 2.692

6.  Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas.

Authors:  Fang Sun; Yangning Hong; Hexuan Zhang; Xiaoli Liu; Zhigang Zhao; Hongbo He; Zhencheng Yan; Zhiming Zhu
Journal:  BMC Endocr Disord       Date:  2021-05-31       Impact factor: 2.763

Review 7.  Frequently asked questions and answers (if any) in patients with adrenal incidentaloma.

Authors:  F Ceccato; M Barbot; C Scaroni; M Boscaro
Journal:  J Endocrinol Invest       Date:  2021-06-23       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.